Divalproex Sodium Tablet, Delayed Release
Product Images NDC 72162-2460

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 72162-2460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (2d6a3b2a 08f3 432d 8fdf B554410153b6 1830 2)

FDA Label Image

Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 01)

FDA Label Image

Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 02)

FDA Label Image

Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 03)

FDA Label Image

Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 04)

FDA Label Image

Image (D405e38e 5f4d 4977 B36b Fca8c23cf294 05)

FDA Label Image

Label (Lbl721622460)

This text provides information about an enteric-coated delayed-release tablet containing Divalproex Sodium, USP, equivalent to Valproic acid 250 mg. The tablets are to be stored at 20° to 25°C and kept out of reach of children. It also mentions the importance of dispensing the Medication Guide to each patient. The package insert includes a QR code for prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.